NCT02215902View on ClinicalTrials.gov

Safety Study of the Aethlon Hemopurifier

NATerminatedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

March 10, 2017

Study Completion Date

March 10, 2017

Conditions
End Stage Renal DiseaseHepatitis C Infection
Interventions
DEVICE

Affinity plasmapheresis

Insert investigational affinity plasma filter into hemodialysis circuit during routine hemodialysis treatments.

Trial Locations (1)

77004

DaVita Med Center Dialysis, Houston

Sponsors
All Listed Sponsors
lead

Aethlon Medical Inc.

INDUSTRY